In an environment with ever more powerful computing possibilities, new drugs under development, and the constant need to evaluate the effectiveness of complex treatment choices, medical imaging is an integral and growing part of medical practice.
Our vision is to build image processing and analysis expertise, and novel quantification techniques to position Feedback as a medical imaging tools company. Our mission is to build tools that extract every ounce of benefit from medical images. We develop innovative techniques and improved workflow for medical practitioners involved in research and in treating patients. We build products that put new and effective tools into the hands of clinical decision makers, with a view to improving patient care and reducing costs.
TexRAD has already proven its value in medical research and is now working towards regulatory approval when it can be used to enrich clinical trials and help understand the effects of new pharmaceuticals.
It is intended that products will be developed to help medical decision makers evaluate the treatment choices on a patient-by-patient basis and which are intended to support industry moves towards a personalised approach to patient care. As its technologies are manufacturer neutral, and can be used with historical images, for example on longitudinal research projects and to monitor disease progression, the addressable market includes all existing specialist imaging centres.
Our aim is to identify imaging biomarkers that can be used in the early detection of cancer, in determining prognosis and predicted outcomes, and in evaluating treatment response.
Building on CCI and TexRAD, we’re always looking for opportunities to widen our offerings through collaborations and corporate activity, including mergers and acquisitions.